MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Traber, P. G.
Right arrow Articles by Gumucio, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Traber, P. G.
Right arrow Articles by Gumucio, J. J.

P450IIB gene expression in rat small intestine: cloning of intestinal P450IIB1 mRNA using the polymerase chain reaction and transcriptional regulation of induction

PG Traber, W Wang, M McDonnell and JJ Gumucio

Department of Internal Medicine, Ann Arbor Veterans Administration Medical Center, Michigan.

Intestinal cytochromes P450 (P450) may function in the "first pass" metabolism of drugs, the detoxification of xenobiotics, or the activation of carcinogens. However, little is known about the expression of specific P450 genes in intestinal mucosa. We have previously shown that a P450 mRNA that is homologous to rat liver P450IIB1 (P450b) is expressed in rat small intestine and is inducible by phenobarbital, polyhalogenated biphenyls, and organochlorine pesticides. However, there are multiple highly homologous genes in the IIB subfamily and, therefore, studies using liver-derived cDNAs or oligonucleotides based on those cDNAs cannot definitively establish the identity of the intestinal mRNA(s). The polymerase chain reaction was used to enzymatically amplify cDNA synthesized from intestinal and hepatic RNA, and the amplified segments were identified by Southern blot analysis. These studies demonstrated that the amplified segment of the phenobarbital-inducible P450 mRNA in intestine was identical to this same segment of the hepatic P450b mRNA; furthermore, this analysis showed that P450e was not expressed in intestine. To definitively establish the identity of the intestinal mRNA, the full coding sequence of the P450b mRNA was cloned from intestinal and hepatic RNA and sequenced. The sequences of the intestinal and hepatic cDNA were identical and coded for P450b; the deduced protein sequence in the F344 rat differed in one amino acid from the reported sequence in Sprague- Dawley rats and, thus, represents a different allele of the same gene. An increment in intestinal P450b mRNA was detected as early as 1 hr following a single intraperitoneal injection of phenobarbital; this prompt rise in mRNA suggested that transcriptional activation may be the primary mechanism for induction. Nuclear run-on experiments were performed using nuclei isolated from intestinal mucosa 3 and 6 hr following treatment with phenobarbital. The rate of transcription of the P450IIB1 gene was increased approximately 6-fold 6 hr following phenobarbital; this was very similar to the increment in P450b mRNA as measured by quantitative dot blot analysis. Therefore, the predominant mechanism for the induction of P450b mRNA in intestine in response to phenobarbital was an increase in gene transcription. These studies indicate that the same member of the P450IIB subfamily, P450IIB1 or P450b, is expressed and inducible by similar mechanisms in small intestine and liver. Although putative P450b mRNA and apoprotein have been identified in lung and testes, the capacity for induction by phenobarbital, and presumably other xenobiotics, is unique to liver and intestine.(ABSTRACT TRUNCATED AT 400 WORDS)

Volume 37, Issue 6, pp. 810-819, 06/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
L. S. Kaminsky and Q.-Y. Zhang
THE SMALL INTESTINE AS A XENOBIOTIC-METABOLIZING ORGAN
Drug Metab. Dispos., December 1, 2003; 31(12): 1520 - 1525.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. M. Nabokina, V. S. Subramanian, and H. M. Said
Comparative analysis of ontogenic changes in renal and intestinal biotin transport in the rat
Am J Physiol Renal Physiol, April 1, 2003; 284(4): F737 - F742.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Gangopadhyay, M. Thamotharan, and S. A. Adibi
Regulation of oligopeptide transporter (Pept-1) in experimental diabetes
Am J Physiol Gastrointest Liver Physiol, July 1, 2002; 283(1): G133 - G138.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Wen and G. D. Wu
Evidence for Epigenetic Mechanisms That Silence Both Basal and Immune-Stimulated Transcription of the IL-8 Gene
J. Immunol., June 15, 2001; 166(12): 7290 - 7299.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. Kishi, T. Tanaka, M. Igawa, S. Takase, and T. Goda
Sucrase-Isomaltase and Hexose Transporter Gene Expressions Are Coordinately Enhanced by Dietary Fructose in Rat Jejunum
J. Nutr., May 1, 1999; 129(5): 953 - 956.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics